Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET

Michael Clark, Mark Nathan, Stephen Broski

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.

Original languageEnglish (US)
Pages (from-to)e308-e310
JournalClinical nuclear medicine
Volume44
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Carcinoid Tumor
Neuroendocrine Tumors
Somatostatin
Radionuclide Imaging
68Ga-DOTATATE
Neoplasms
somatostatin receptor 2

Keywords

  • Ga-DOTATATE PET/CT
  • carcinoid
  • neuroendocrine
  • somatostatin receptor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Multifocal Small Bowel Carcinoid : Evaluation by 68Ga-DOTATATE PET. / Clark, Michael; Nathan, Mark; Broski, Stephen.

In: Clinical nuclear medicine, Vol. 44, No. 4, 01.04.2019, p. e308-e310.

Research output: Contribution to journalArticle

Clark, Michael ; Nathan, Mark ; Broski, Stephen. / Multifocal Small Bowel Carcinoid : Evaluation by 68Ga-DOTATATE PET. In: Clinical nuclear medicine. 2019 ; Vol. 44, No. 4. pp. e308-e310.
@article{12bf7344deeb471e8cbef1ecad4deb2a,
title = "Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET",
abstract = "Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.",
keywords = "Ga-DOTATATE PET/CT, carcinoid, neuroendocrine, somatostatin receptor",
author = "Michael Clark and Mark Nathan and Stephen Broski",
year = "2019",
month = "4",
day = "1",
doi = "10.1097/RLU.0000000000002487",
language = "English (US)",
volume = "44",
pages = "e308--e310",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Multifocal Small Bowel Carcinoid

T2 - Evaluation by 68Ga-DOTATATE PET

AU - Clark, Michael

AU - Nathan, Mark

AU - Broski, Stephen

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.

AB - Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.

KW - Ga-DOTATATE PET/CT

KW - carcinoid

KW - neuroendocrine

KW - somatostatin receptor

UR - http://www.scopus.com/inward/record.url?scp=85062393383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062393383&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002487

DO - 10.1097/RLU.0000000000002487

M3 - Article

C2 - 30762820

AN - SCOPUS:85062393383

VL - 44

SP - e308-e310

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 4

ER -